Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Early Patient Experience Initiative (IMPACT-HTN)

NCT07579260 is registered in ClinicalTrials.gov with Vivek Bhalla as lead sponsor.

NCT NCT07579260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07579260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Early Patient Experience Initiative (IMPACT-HTN)
Lead sponsor
Vivek Bhalla
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
April 1, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, high, hypertension, hypertension (htn)